Will Sargent
About Will Sargent
Will Sargent Senior Vice President Commercial Strategy
Will Sargent currently holds the position of Senior Vice President, Commercial Strategy. With over 25 years of experience in the biopharmaceutical industry, he has a track record of successfully leading commercial initiatives. His role involves strategic oversight of commercial activities, leveraging his extensive background to optimize market strategies.
Education of Will Sargent
Will Sargent obtained a BA in Biology from Johns Hopkins University, providing him with a strong foundation in the life sciences. Furthermore, he earned an MBA from the University of Washington Foster School of Business, equipping him with advanced business management skills tailored for the biopharmaceutical industry.
Professional Experience of Will Sargent
Will Sargent's professional journey spans prominent roles in multiple organizations. He led the launch and commercialization for Xenleta at Nabriva. Additionally, he had leadership roles at Auxilium Pharmaceuticals, including serving as Vice President, Orthopedic Business Unit. His early career includes positions at Amgen and Immunex, where he held various commercial roles.
Will Sargent at Bank of America
Before embarking on his executive roles in the biopharmaceutical industry, Will Sargent worked as a biotechnology equities analyst at Bank of America. This role involved analyzing market trends and providing insights on biotechnology equities, contributing to his comprehensive understanding of biotech markets.
Achievements in Biopharmaceutical Industry
During his extensive career, Will Sargent led the launch and commercialization for Xenleta at Nabriva, showcasing his capability in bringing new biopharmaceutical products to market. His leadership roles at Auxilium Pharmaceuticals and contributions at Amgen and Immunex further highlight his impact in the industry.